On September 20th, Piper Sandler covered Abbott Laboratories for the first time, giving it an 'overweight' rating with a target price of $131.
Piper Sandler首予雅培“增持”评级
Piper Sandler initially assigned an "shareholding" rating to abbott laboratories.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated